Get started
Author

Elena Ostos

Observed names: E Ostos, Elena Ostos Roldán, Elena Ostos-Roldan, Elena Ostos-Roldán, Ostos, E.
ORCID: 0009-0004-9452-5808
Observed ORCID: 0009-0004-9452-5808
OpenAlex ID: A5112077757
Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension
2019 · Joan Jiménez-Balado, Iolanda Riba-Llena, et al. · Hypertension · 89
PDF
Mesangial C4d Deposits in Early IgA Nephropathy
2017 · Alfons Segarra, Katheryne Romero, et al. · Clinical Journal of the American Society of Nephrology · 71
Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience
2019 · A Segarra, K V Arredondo, et al. · Lupus · 68
Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens
2014 · Alfonso Segarra Medrano, Elias Jatem Escalante, et al. · Biomarkers · 36
Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function
2022 · Jorge González, Elias Jatem, et al. · Nephrology Dialysis Transplantation · 35
Valor de los niveles urinarios de interleucina 6, factor de crecimiento epidérmico, proteína quimioatractante de monocitos de tipo 1 y factor de crecimiento transformante β1 para la predicción de la extensión de las lesiones de fibrosis en biopsias de enfermos con nefropatía IgA
2017 · Alfons Segarra-Medrano, Clara Carnicer-Caceres, et al. · Nefrología · 30
PDF
Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus.
2014 · Alfons Segarra-Medrano, Elias Jatem-Escalante, et al. · PubMed · 28
Microalbuminuria and the Combination of MRI Markers of Cerebral Small Vessel Disease
2016 · Andrea Vilar-Bergua, Iolanda Riba-Llena, et al. · Cerebrovascular Diseases · 23
Biological markers of nephrotic syndrome: a few steps forward in the long way.
2012 · Alfonso Segarra-Medrano, Clara Carnicer-Cáceres, et al. · PubMed · 22
Estudio de las variables asociadas a la activación local del complemento en la nefropatía IgA idiopática
2017 · Alfons Segarra-Medrano, Clara Carnicer-Caceres, et al. · Nefrología · 20
PDF
Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy
2025 · Jorge González Rodríguez, Jose Manuel Valdivielso, et al. · BMC Nephrology · 11
Study of the variables associated with local complement activation in IgA nephropathy
2017 · Alfons Segarra-Medrano, Clara Carnicer-Caceres, et al. · Nefrología (English Edition) · 11
PDF
Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors.
2013 · Alfonso Segarra-Medrano, Elias Jatem-Escalante, et al. · PubMed · 9
Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type 1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy
2017 · Alfons Segarra-Medrano, Clara Carnicer-Caceres, et al. · Nefrología (English Edition) · 8
PDF
#56 Development of a multiple biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA nephropathy
2025 · Jorge González Rodríguez, Elías Jatem Escalante, et al. · Nephrology Dialysis Transplantation
PDF
Supplementary Material for: Microalbuminuria and the Combination of MRI Markers of Cerebral Small Vessel Disease
2016 · Vilar-Bergua, A., Riba-Llena, I., et al. · Figshare
Works count: 18
Citation count: 461
H-index: 11
I10-index: 12
Year
Topic
Type